Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Avita Medical.
RELATED STOCKHEAD STORIES
News
After Neuren’s success, which other ASX health stocks are knocking on the US FDA door?
News
Rise and Shine: Everything you need to know before the ASX opens
News
Weekly Small Caps and IPO Wrap: Data, data everywhere, but nary a spot to think
News
CLOSING BELL: Shipments increase after China lifts the ban it never put on Aussie coal
News
ASX Small Caps Lunch Wrap: Who needs a few lessons on how to run their socials this morning?
News
Closing Bell: ASX finishes up, but microcaps and base metals feel the heat
Health & Biotech
Here’s why Morningstar reckons the ASX healthcare sector is on road to recovery
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall this week and in need of a good rest after a tough 2022
Experts
ScoPo’s Powerplays: Stress eases as ASX health stocks enjoy much needed rally
Health & Biotech
ASX Health Stocks: Patent updates from Cynata and Proteomics; Ramsay sees good times ahead
Health & Biotech
ASX Health Stocks: Avita makes crucial announcement on its pivotal RECELL trial, shares up 9pc
Health & Biotech
Check Up: These 4 ASX healthcare stocks come with Strong Buy recommendations
Experts
Innovation never sleeps: Franklin Templeton says watch these 5 big tech shifts this quarter
News
Market Highlights: US bans Nvidia chips in China; and 5 ASX small caps to watch on Friday
Experts
ScoPo’s Powerplays: Reporting season positive as ASX health stocks head in right direction
News
Closing Bell: It must be Funky Friday, because it’s smelling pretty crook at the end of the day
News